|  |  | Probability by treatment |  |  |
---|---|---|---|---|---|
 |  | Atomoxetine | IR-MPH | XR-MPH | No medication |
Probability of one or more medication-related adverse eventsa | Â | 0.129 | 0.129 | 0.129 | 0.000 |
Probability that a medication-related adverse event is insomniab | Â | 0.000 | 0.48 | 0.48 | NA |
Probability that a medication-related adverse event, which is not insomniac | First 4 cycles | 0.473 | 0.473 | 0.473 | NA |
 | Cycles thereafter | 1.000 | 1.000 | 1.000 | NA |
Probability that insomnia will persist from one Markov cycle to the nextd | First 4 cycles | NA | 0.953 | 0.953 | NA |
 | Cycles thereafter | NA | 1.000 | 1.000 | NA |
Probability that a non-responder discontinues due to lack of efficacy during a Markov cyclee | Â | 0.0989 | 0.0989 | 0.0989 | NA |
Probability that a patient discontinue due to a medication-related adverse event during a Markov cyclef | Â | 0.1209 | 0.1209 | 0.1209 | NA |
Probability that a patient discontinues for reasons other than lack of efficacy or a medication-related adverse event during a Markov cyclee | First 4 cycles | 0.384 | 0.384 | 0.384 | NA |
 | Cycles thereafter | 0.000 | 0.000 | 0.000 | NA |